SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve the Unaudited (Standalone ....
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Saturday, 7th February 2026, at the registered office in Hyderabad. The key agenda item is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the third quarter (Q3) and nine months ended 31st December 2025. The company has also confirmed that the trading window for insiders is closed from 1st January 2026 until 9th February 2026, reopening on 10th February 2026, in line with insider trading regulations. This is a standard regulatory intimation filed under SEBI LODR Regulation 29.
No direct impact on shareholders or stock price from this filing alone. Investors should watch for the actual Q3 FY26 results announcement on or after 7th February, which could move the stock depending on the numbers versus expectations.